ERBB2 and breast carcinoma: These include BRAF V600 mutation for melanoma [6], EGFR mutation [7] and ALK fusion for lung cancer [8], HER2 amplification or overexpression for breast cancer [9], and KRAS mutation for colorectal cancer [10].